JG
TXMD icon

Jefferies Group’s TherapeuticsMD TXMD Stock Holding History

Jefferies Group’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,401
Closed -$74K – 2040
2020
Q1 		$74K Buy
+1,401
New +$139K ﹤0.01% 1836
2019
Q4 		– Sell
-581
Closed -$83.5K – 3021
2019
Q3 		$106K Sell
581
-926
-61% -$131K ﹤0.01% 2500
2019
Q2 		$196K Buy
+1,507
New +$270K ﹤0.01% 2144
2019
Q1 		– Sell
-224
Closed -$43K – 2646
2018
Q4 		$43K Sell
224
-74
-25% -$18.1K ﹤0.01% 2037
2018
Q3 		$98K Buy
298
+2
+0.7% +$613 ﹤0.01% 2223
2018
Q2 		$92K Buy
296
+8
+3% +$2.44K ﹤0.01% 2149
2018
Q1 		$70K Buy
+288
New +$80.8K ﹤0.01% 2103
2016
Q2 		– Sell
-402
Closed -$129K – 2451
2016
Q1 		$129K Buy
+402
New +$137K ﹤0.01% 1932
2015
Q3 		– Sell
-2,312
Closed -$909K – 3033
2015
Q2 		$909K Buy
+2,312
New +$816K ﹤0.01% 1291
2015
Q1 		– Sell
-3,070
Closed -$683K – 2388
2014
Q4 		$683K Buy
+3,070
New +$633K ﹤0.01% 1139
2014
Q3 		– Sell
-142
Closed -$35.8K – 2452
2014
Q2 		$31K Sell
142
-24,130
-99% -$5.37M ﹤0.01% 1957
2014
Q1 		$7.66M Buy
+24,272
New +$7.73M 0.07% 210

Other funds holding TXMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jefferies Group's TXMD Position: Q2 2020 in Review

Jefferies Group sold out of TherapeuticsMD (TXMD) in Q2 2020, closing a stake of 1,401 shares — an estimated $74K sold.

Jefferies Group first reported a position in TXMD in Q1 2014 and held it in 12 quarters. The position peaked at $7.66M in Q1 2014. 149 funds tracked by Wall St. Rank hold TXMD as of Q2 2020.

  • Jefferies Group reported no remaining TherapeuticsMD position as of Q2 2020 after selling out during the quarter.
  • Jefferies Group sold 1,401 TherapeuticsMD shares in Q2 2020, an estimated $74K.
  • Jefferies Group first reported a position in TherapeuticsMD in Q1 2014 and held it in 12 quarters.
  • Jefferies Group's TherapeuticsMD position peaked at $7.66M in Q1 2014.
  • 149 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2020.

Based on Jefferies Group's 13F filing for Q2 2020, filed 14 Aug 2020.